Safety and Efficacy of γδ T Cell Against Gastric Cancer
In this study, safety and effects of γδT cells on human gastric cancer are going to be investigated.
Gastric Cancer
BIOLOGICAL: CIK|BIOLOGICAL: γδ T|BIOLOGICAL: CIK and γδ T
Reduced size of the tumor., Tumor load will be evaluated by RECIST criteria., up to one year
Safety, as measured by the rate of adverse events and serious adverse events, Safety, as measured by the rate of adverse events and serious adverse events, up to two years
PBMC of the patient will be separated from peripheral blood. After making them potential cancer killer γδ T Cell and CIK, they will be infused to the patients as immunotherapy.